Cargando…
Cephalosporin-Glycopeptide Combinations for Use against Clinical Methicillin-Resistant Staphylococcus aureus Isolates: Enhanced In vitro Antibacterial Activity
The empirical combination of both a beta-lactam and glycopeptide to counter potential staphylococcal pathogens may improve the clinical outcomes for cases of Staphylococcus aureus bacteremia. We reported comparative in vitro studies of combination effects of different cephalosporins (i.e., cefazolin...
Autores principales: | Tang, Hung-Jen, Lai, Chih-Cheng, Chen, Chi-Chung, Zhang, Chun-Cheng, Weng, Tzu-Chieh, Yu, Wen-Liang, Chen, Hung-Jui, Chiu, Yu-Hsin, Ko, Wen-Chien, Chuang, Yin-Ching |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435797/ https://www.ncbi.nlm.nih.gov/pubmed/28572795 http://dx.doi.org/10.3389/fmicb.2017.00884 |
Ejemplares similares
-
Combination of cephalosporins with vancomycin or teicoplanin enhances antibacterial effect of glycopeptides against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and VISA
por: Lai, Chih-Cheng, et al.
Publicado: (2017) -
Impact of Molecular Epidemiology and Reduced Susceptibility to Glycopeptides and Daptomycin on Outcomes of Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Lee, Hao-Yuan, et al.
Publicado: (2015) -
Timing of Initiating Glycopeptide Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: The Impact on Clinical Outcome
por: Lee, Chen-Hsiang, et al.
Publicado: (2013) -
Ceftaroline fosamil: A novel anti-Methicillin-resistant Staphylococcus aureus cephalosporin
por: Girish, C., et al.
Publicado: (2011) -
Methicillin-resistant Staphylococcus aureus in Taiwan
por: Chen, Feng-Jui, et al.
Publicado: (2005)